Rechercher
Contactez-nous Suivez-nous sur Twitter En francais English Language
 

Freely subscribe to our NEWSLETTER

Newsletter FR

Newsletter EN

Vulnérabilités

Unsubscribe

Darktrace in $65 million Fundraise to Accelerate Global Expansion in Round led by KKR

July 2016 by Emmanuelle Lamandé

Darktrace announced that it has raised new growth equity financing, led by KKR, a global investment firm, with participation from existing investor Summit Partners, and new investors TenEleven Ventures and SoftBank-affiliated SB ISAT Fund. Invoke Capital first identified Darktrace’s differentiated approach to cybersecurity threats and funded Darktrace in 2013, providing operational expertise since. Darktrace will use the funds to further accelerate the global roll-out of its Enterprise Immune System technology.

Using advanced mathematics and machine learning techniques based on the biological principles of the human immune system, Darktrace addresses the challenge of detecting and responding to cyber threats that evade existing solutions. Darktrace is capable of identifying new, emerging threats within computer networks in real time including insider attacks, ransomware, machine-based attacks, and unknown threat scenarios.

Founded in 2013, Darktrace has grown rapidly to 300 employees and has achieved over 600% revenue growth in its latest financial year. With over 1,000 customer deployments, Darktrace’s Enterprise Immune System has been selected by some of the largest cyber security environments, including global financial institutions, telecommunications networks, legal firms, retailers, technology companies, government organizations, and critical national infrastructure facilities.


See previous articles

    

See next articles


Your podcast Here

New, you can have your Podcast here. Contact us for more information ask:
Marc Brami
Phone: +33 1 40 92 05 55
Mail: ipsimp@free.fr

All new podcasts